Our solution.

Cost-effective, comprehensive, personalized pharmacogenomic analysis — integrated into patients' everyday clinical care

Why pharmacogenomics?

Up to 95% of your response to drugs is genetically determined, and how you metabolize drugs is one of the factors contributing to that response.1 With pharmacogenomics (PGx), we identify which inherited genetic variations a person has to predict how an individual will — or will not — metabolize a drug.

How people metabolize drugs

  • PM icon
    Poor metabolizer (PM)
    Metabolizes drugs much
    more slowly than normal.
  • IM icon
    Intermediate metabolizer (IM)
    Metabolizes more
    slowly than normal.
  • EM icon
    Normal metabolizer (NM)
    Metabolizes at a
    normal rate.
  • UM icon
    Ultrarapid metabolizer (UM)
    Metabolizes more
    quickly than normal.



In addition to standard characteristics such as sex, age, race, and liver function, PGx results may help your physician prescribe you the right medication. Knowing your metabolizer status for many drugs will help your physician determine which drug may work for you and reduces the trial-and-error approach. Being a "normal" metabolizer means your physician can prescribe a drug as directed by the FDA label. If you are a poor metabolizer, you may need a dosage adjustment to avoid side effects or improve the drug’s effectiveness. Your metabolizer status is determined by your genes, which never change; thus, if you are a poor metabolizer of a given drug, you will always be a poor metabolizer of that drug.

PGx has the potential to increase the safety and effectiveness of drug treatments by incorporating genetic data to better predict an individual’s response to medications and adverse drug reactions (ADRs).


Adverse drug reactions (ADRs) are the fourth leading cause of death in the U.S., and according to the FDA, cost $136 billion annually. 2

The OneOme solution

OneOme's RightMed® pharmacogenomic test and clinical decision support system combine a patient's genetic profile and prescription history with a proprietary algorithm-based platform

OneOme engine graphic OneOme engine graphic

Co-developed and exclusively licensed from Mayo Clinic, OneOme’s unique platform is:

  • comprehensive icon
      COMPREHENSIVE
      Rigorous, proprietary analysis that includes 22 genes and more than 340 of the most commonly prescribed medications across multiple disease areas
  • individualized icon
      INDIVIDUALIZED
      Comprised of a patient's genetic information, medication history, and drug-to-drug interactions to produce a lifelong individualized resource of drug response
  • credible icon
      CREDIBLE
      Characterized by clinical evidence collected from FDA label information, Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines and reproducible studies from scientific literature3,4
  • actionable icon
      ACTIONABLE
      Both enhanced static and interactive reports for easy readability and quick decision-making within the provider workflow
  • accessible icon
      ACCESSIBLE
      Affordable — offered as a low-cost, out-of-pocket expense to everyone
  • service icon
      CONVENIENT
      Customized 24/7 logistics and customer support including expert medical, genetics, and pharmacology staff on call

Benefits of the OneOme RightMed PGx test

Our goal is to bring reliable, comprehensive pharmacogenomic insights to providers and patients.

Aiming to:

  • side effects icon
    Reduce side
    effects
  • adverse reactions icon
    Limit potential
    adverse reactions
  • effectiveness icon
    Increase drug
    effectiveness
  • interactions icon
    Prevent unintended
    interactions between
    other drugs
  • efficient icon
    Make our
    healthcare system
    more efficient

When testing can help

Until now, providers and pharmacists had to rely on trial and error to find the right drug for each patient. OneOme brings clarity and insight into new and existing medication. OneOme's RightMed PGx test may help with:

  • reactive icon
      CURRENT PRESCRIPTIONS (REACTIVELY)
      Get insight into why a patient might be experiencing adverse effects or is not experiencing the expected benefits from a drug they're already taking.
  • proactive icon
      PRESCRIPTION DECISIONS (PROACTIVELY)
      Before prescribing a new medication, leverage a patient's PGx profile to make more informed decisions.

Because DNA does not change with time, the OneOme RightMed PGx test may provide years of more accurate decision-making.

oneome circle logo

Want to know more?